Table 2

Results of immunohistochemistry on non–small cell lung carcinoma tissue sections expressed as the number of tumors labeled after incubation with anti-Epo, anti-Epo-R, and anti-HIF-1α antibodies

EpoEpo-REpo/Epo-RHIF-1αHIF1α/Epo
Squamous cell carcinomas5/12 (42%)12/12 (100%)5/12 (42%)10/10 (100%)5/10 (50%)
Adenocarcinomas7/12 (58%)11/12 (92%)7/12 (58%)6/10 (60%)4/10 (40%)
Total12/24 (50%)23/24 (96%)12/24 (50%)16/20 (80%)9/20 (45%)
  • NOTE. Co-expressions of Epo and Epo-R as well as Epo and HIF-1α evaluated on serial sections are also indicated.